Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy von Owen, C.N., Shoushtari, A.N., Chauhan, D., Palmieri, D.J., Lee, B., Rohaan, M.W., Mangana, J., Atkinson, V., Zaman, F., Young, A., Hoeller, C., Hersey, P., Dummer, R., Khattak, M.A., Millward, M., Patel, S.P., Haydon, A., Johnson, D.B., Lo, S., Blank, C.U., Sandhu, S., Carlino, M.S., Larkin, J.M.G., Menzies, A.M., Long, G.V.

Volltext

Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma von Fraterman, Itske, Reijers, Irene L. M., Dimitriadis, Petros, Broeks, Annegien, Gonzalez, M., Menzies, A. M. M., Lopez-Yurda, Marta, Kapiteijn, Ellen, van der Veldt, Astrid A. M., Suijkerbuijk, Karijn P. M., Hospers, Geke A. P., Long, Georgina V., Blank, Christian U., van de Poll-Franse, Lonneke V.

Volltext

Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma von Carlino, M S, Haydu, L E, Kakavand, H, Menzies, A M, Hamilton, A L, Yu, B, Ng, C C, Cooper, W A, Thompson, J F, Kefford, R F, O'Toole, S A, Scolyer, R A, Long, G V

Volltext

Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections von Schmitt, C., Hoefsmit, E. P., Fangmeier, T., Kramer, N., Kabakci, C., Vera González, J., Versluis, J. M., Compter, A., Harrer, T., Mijočević, H., Schubert, S., Hundsberger, T., Menzies, A. M., Scolyer, R. A., Long, G. V., French, L. E., Blank, C. U., Heinzerling, L. M.

Volltext

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy von Haanen, J., Ernstoff, M.S., Wang, Y., Menzies, A.M., Puzanov, I., Grivas, P., Larkin, J., Peters, S., Thompson, J.A., Obeid, M.

Volltext

Novel adjuvant options for cutaneous melanoma von Dimitriou, F., Long, G.V., Menzies, A.M.

Volltext

BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma von Wilmott, J S, Menzies, A M, Haydu, L E, Capper, D, Preusser, M, Zhang, Y E, Thompson, J F, Kefford, R F, von Deimling, A, Scolyer, R A, Long, G V

Volltext

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab von Menzies, A.M., Johnson, D.B., Ramanujam, S., Atkinson, V.G., Wong, A.N.M., Park, J.J., McQuade, J.L., Shoushtari, A.N., Tsai, K.K., Eroglu, Z., Klein, O., Hassel, J.C., Sosman, J.A., Guminski, A., Sullivan, R.J., Ribas, A., Carlino, M.S., Davies, M.A., Sandhu, S.K., Long, G.V.

Volltext

On and Off the North China Craton: Where is the Archaean Keel? von FAN, W. M., ZHANG, H. F., BAKER, J., JARVIS, K. E., MASON, P. R. D., MENZIES, M. A.

Volltext

Immunotherapy use outside clinical trial populations: never say never? von Rzeniewicz, K., Larkin, J., Menzies, A.M., Turajlic, S.

Volltext

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma von Pollack, M.H., Betof, A., Dearden, H., Rapazzo, K., Valentine, I., Brohl, A.S., Ancell, K.K., Long, G.V., Menzies, A.M., Eroglu, Z., Johnson, D.B., Shoushtari, A.N.

Volltext

The Geochemistry of the Arabian Lithospheric Mantle-a Source for Intraplate Volcanism? von Shaw, J. E., Baker, J. A., Kent, A. J. R., Ibrahim, K. M., Menzies, M. A.

Volltext

FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma von Tan, A.C., Emmett, L., Lo, S., Liu, V., Kapoor, R., Carlino, M.S., Guminski, A.D., Long, G.V., Menzies, A.M.

Volltext

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma von Lee, J.H., Long, G.V., Boyd, S., Lo, S., Menzies, A.M., Tembe, V., Guminski, A., Jakrot, V., Scolyer, R.A., Mann, G.J., Kefford, R.F., Carlino, M.S., Rizos, H.

Volltext

Cutaneous sarcoidosis due to immune‐checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor von Pham, J. P., Star, P., Wong, S., Damian, D. L., Saw, R. P. M., Whitfeld, M. J., Menzies, A. M., Joshua, A. M., Smith, A.

Volltext

PET imaging for cancer immunotherapy: the Immuno-PET von Menzies, A.M., Lastoria, S.

Volltext

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma von Jansen, Y.J.L., Rozeman, E.A., Mason, R., Goldinger, S.M., Geukes Foppen, M.H., Hoejberg, L., Schmidt, H., van Thienen, J.V., Haanen, J.B.A.G., Tiainen, L., Svane, I.M., Mäkelä, S., Seremet, T., Arance, A., Dummer, R., Bastholt, L., Nyakas, M., Straume, O., Menzies, A.M., Long, G.V., Atkinson, V., Blank, C.U., Neyns, B.

Volltext

OpACIN-neo: A multicenter phase II study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO) von Blank, C.U., Rozeman, E.A., Menzies, A.M., van de Wiel, B.A., Adhikari, C., Sikorska, K., Krijgsman, O., Eriksson, H., Bierman, C., Grijpink-Ongering, L., Gonzalez, M., Broeks, A., Guminski, A.D., Spillane, A.J., Klop, W.M.C., Saw, R.P.M., Scolyer, R.A., van Akkooi, A.C.J., Hansson, J., Long, G.V.

Volltext

Ongoing partial response at 6 months to olaparib for metastatic melanoma with somatic PALB2 mutation after failure of immunotherapy: a case report von Lau, B., Menzies, A.M., Joshua, A.M.

Volltext

Late glacial explosive activity on Mount Etna: Implications for proximal–distal tephra correlations and the synchronisation of Mediterranean archives von Albert, P.G., Tomlinson, E.L., Lane, C.S., Wulf, S., Smith, V.C., Coltelli, M., Keller, J., Lo Castro, D., Manning, C.J., Müller, W., Menzies, M.A.

Volltext